RxDoctor Payments Data

Amy Askew, MD

Urogynecology and Reconstructive Pelvic Surgery · Raleigh, NCNPI 1508251182

Payments from drug & device makers

What this record shows

Axonics, Inc. accounts for 62.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,159 and has fallen 98.1% since, to $41 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in NC, where the typical reported total is $4,140.

$4,140in general payments, 2019–2025

Across 70 payments — averaging $59.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$3K
  • Medtronic$1K
  • Boston Scientific$232
  • Coloplast$75
  • Optumhealth Care Solutions, LLC$65
  • Applied Medical Resources Corporation$37

What the payments were for

  • Travel & lodging$2,43559%
  • Food & beverage$1,70541%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axonics, Inc.45$2,600
Medtronic15$1,130
Boston Scientific5$232
Coloplast1$75
Optumhealth Care Solutions, LLC3$65
Applied Medical Resources Corporation1$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,140 in reported general payments places this provider in the 50th percentile of 35 urogynecology and reconstructive pelvic surgery providers in North Carolina.

See all urogynecology and reconstructive pelvic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$169,157
Medicare patients
265
Services billed
2,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron168$142,543
MyrbetriqMirabegron99$66,107
Mirabegron ErMirabegron13$8,858
Estradiol96$5,779
Clobetasol Propionate82$2,890
Methenamine Hippurate14$850
Trimethoprim21$700
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst33$349
Solifenacin Succinate16$174
Ibuprofen50$155
Gabapentin11$96
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim54$79
Oxycodone Hcl62$62
Ciprofloxacin Hcl14$50

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →